Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease | Cardiology | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
1.
Caplan  LR.  Vertebrobasilar disease.  Adv Neurol. 2003;92:131-140.PubMedGoogle Scholar
2.
Caplan  LR, Wityk  RJ, Glass  TA,  et al.  New England Medical Center Posterior Circulation registry.  Ann Neurol. 2004;56(3):389-398.PubMedGoogle ScholarCrossref
3.
Gulli  G, Marquardt  L, Rothwell  PM, Markus  HS.  Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies.  Stroke. 2013;44(3):598-604.PubMedGoogle ScholarCrossref
4.
Derdeyn  CP, Chimowitz  MI, Lynn  MJ,  et al; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.  Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.  Lancet. 2014;383(9914):333-341.PubMedGoogle ScholarCrossref
5.
Qureshi  AI, Ziai  WC, Yahia  AM,  et al.  Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study.  Neurosurgery. 2003;52(5):1033-1039.PubMedGoogle ScholarCrossref
6.
The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group.  Prognosis of patients with symptomatic vertebral or basilar artery stenosis.  Stroke. 1998;29(7):1389-1392.PubMedGoogle ScholarCrossref
7.
Moufarrij  NA, Little  JR, Furlan  AJ, Leatherman  JR, Williams  GW.  Basilar and distal vertebral artery stenosis: long-term follow-up.  Stroke. 1986;17(5):938-942.PubMedGoogle ScholarCrossref
8.
Abuzinadah  AR, Alanazy  MH, Almekhlafi  MA,  et al.  Stroke recurrence rates among patients with symptomatic intracranial vertebrobasilar stenoses: systematic review and meta-analysis [published online December 11, 2014].  J Neurointerv Surg.PubMedGoogle Scholar
9.
Ausman  JI, Diaz  FG, Vacca  DF, Sadasivan  B.  Superficial temporal and occipital artery bypass pedicles to superior, anterior inferior, and posterior inferior cerebellar arteries for vertebrobasilar insufficiency.  J Neurosurg. 1990;72(4):554-558.PubMedGoogle ScholarCrossref
10.
Hopkins  LN, Budny  JL.  Complications of intracranial bypass for vertebrobasilar insufficiency.  J Neurosurg. 1989;70(2):207-211.PubMedGoogle ScholarCrossref
11.
Gröschel  K, Schnaudigel  S, Pilgram  SM, Wasser  K, Kastrup  A.  A systematic review on outcome after stenting for intracranial atherosclerosis.  Stroke. 2009;40(5):e340-e347.PubMedGoogle ScholarCrossref
12.
Nahab  F, Lynn  MJ, Kasner  SE,  et al; NIH Multicenter Wingspan Intracranial Stent Registry Study Group.  Risk factors associated with major cerebrovascular complications after intracranial stenting.  Neurology. 2009;72(23):2014-2019.PubMedGoogle ScholarCrossref
13.
Zaidat  OO, Fitzsimmons  BF, Woodward  BK,  et al; VISSIT Trial Investigators.  Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.  JAMA. 2015;313(12):1240-1248.PubMedGoogle ScholarCrossref
14.
Derdeyn  CP, Grubb  RL  Jr, Powers  WJ.  Cerebral hemodynamic impairment: methods of measurement and association with stroke risk.  Neurology. 1999;53(2):251-259.PubMedGoogle ScholarCrossref
15.
Amin-Hanjani  S, Du  X, Zhao  M, Walsh  K, Malisch  TW, Charbel  FT.  Use of quantitative magnetic resonance angiography to stratify stroke risk in symptomatic vertebrobasilar disease.  Stroke. 2005;36(6):1140-1145.PubMedGoogle ScholarCrossref
16.
Amin-Hanjani  S, Rose-Finnell  L, Richardson  D,  et al; VERiTAS Study Group.  Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design.  Int J Stroke. 2010;5(6):499-505.PubMedGoogle ScholarCrossref
17.
Amin-Hanjani  S, Du  X, Rose-Finnell  L,  et al; VERiTAS Study Group.  Hemodynamic features of symptomatic vertebrobasilar disease.  Stroke. 2015;46(7):1850-1856.PubMedGoogle ScholarCrossref
18.
Chobanian  AV, Bakris  GL, Black  HR,  et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  Hypertension. 2003;42(6):1206-1252.PubMedGoogle ScholarCrossref
19.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.  Circulation. 2002;106(25):3143-3421.PubMedGoogle Scholar
20.
American Diabetes Association.  Standards of medical care in diabetes—2007.  Diabetes Care. 2007;30(suppl 1):S4-S41.PubMedGoogle ScholarCrossref
21.
Sacco  RL, Adams  R, Albers  G,  et al; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.  Stroke. 2006;37(2):577-617.PubMedGoogle ScholarCrossref
22.
Adams  RJ, Albers  G, Alberts  MJ,  et al; American Heart Association; American Stroke Association.  Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.  Stroke. 2008;39(5):1647-1652.PubMedGoogle ScholarCrossref
23.
Samuels  OB, Joseph  GJ, Lynn  MJ, Smith  HA, Chimowitz  MI.  A standardized method for measuring intracranial arterial stenosis.  AJNR Am J Neuroradiol. 2000;21(4):643-646.PubMedGoogle Scholar
24.
Marquardt  L, Kuker  W, Chandratheva  A, Geraghty  O, Rothwell  PM.  Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study.  Brain. 2009;132(Pt 4):982-988.PubMedGoogle Scholar
25.
Gulli  G, Khan  S, Markus  HS.  Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA.  Stroke. 2009;40(8):2732-2737.PubMedGoogle ScholarCrossref
26.
Kozak  O, Tariq  N, Suri  MF, Taylor  RA, Qureshi  AI.  High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis.  Neurosurgery. 2011;69(2):334-342.PubMedGoogle ScholarCrossref
27.
Mohan  KM, Crichton  SL, Grieve  AP, Rudd  AG, Wolfe  CD, Heuschmann  PU.  Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register.  J Neurol Neurosurg Psychiatry. 2009;80(9):1012-1018.PubMedGoogle ScholarCrossref
28.
Grubb  RL  Jr, Derdeyn  CP, Fritsch  SM,  et al.  Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.  JAMA. 1998;280(12):1055-1060.PubMedGoogle ScholarCrossref
29.
Caplan  LR, Hennerici  M.  Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke.  Arch Neurol. 1998;55(11):1475-1482.PubMedGoogle ScholarCrossref
30.
Wang  Y, Wang  Y, Zhao  X,  et al; CHANCE Investigators.  Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.  N Engl J Med. 2013;369(1):11-19.PubMedGoogle ScholarCrossref
31.
Chimowitz  MI, Lynn  MJ, Howlett-Smith  H,  et al; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.  N Engl J Med. 2005;352(13):1305-1316.PubMedGoogle ScholarCrossref
32.
Guppy  KH, Charbel  FT, Corsten  LA, Zhao  M, Debrun  G.  Hemodynamic evaluation of basilar and vertebral artery angioplasty.  Neurosurgery. 2002;51(2):327-333.PubMedGoogle Scholar
33.
Fiorella  D, Derdeyn  CP, Lynn  MJ,  et al; SAMMPRIS Trial Investigators.  Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).  Stroke. 2012;43(10):2682-2688.PubMedGoogle ScholarCrossref
Original Investigation
February 2016

Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease

Author Affiliations
  • 1Department of Neurosurgery, University of Illinois at Chicago
  • 2Department of Neurology and Rehabilitation, University of Illinois at Chicago
  • 3Department of Mathematics & Computer Science, Lake Forest College, Lake Forest, Illinois
  • 4Center for Magnetic Resonance Research, University of Illinois at Chicago
  • 5Departments of Neurology and Epidemiology, Columbia University, New York, New York
  • 6Departments of Neurosurgery and Neurology, Washington University in St Louis, St Louis, Missouri
  • 7Department of Neurology, UCLA (University of California, Los Angeles)
  • 8Department of Medicine, Division of Neurology, University of Toronto, Toronto, Ontario, Canada
  • 9Department of Neurology, University of Pennsylvania, Philadelphia
  • 10Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
  • 11Mallinkrodt Institute of Radiology, Washington University in St Louis, St Louis, Missouri
  • 12Department of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine, Grand Rapids, Michigan
  • 13Mercy Health Hauenstein Neurosciences, Grand Rapids, Michigan
JAMA Neurol. 2016;73(2):178-185. doi:10.1001/jamaneurol.2015.3772
Abstract

Importance  Atherosclerotic vertebrobasilar (VB) occlusive disease is a significant etiology of posterior circulation stroke, with regional hypoperfusion as an important potential contributor to stroke risk.

Objective  To test the hypothesis that, among patients with symptomatic VB stenosis or occlusion, those with distal blood flow compromise as measured by large-vessel quantitative magnetic resonance angiography (QMRA) are at higher risk of subsequent posterior circulation stroke.

Design, Setting, and Participants  A prospective, blinded, longitudinal cohort study was conducted at 5 academic hospital-based centers in the United States and Canada; 82 patients from inpatient and outpatient settings were enrolled. Participants with recent VB transient ischemic attack or stroke and 50% or more atherosclerotic stenosis or occlusion in vertebral and/or basilar arteries underwent large-vessel flow measurement in the VB territory using QMRA. Physicians performing follow-up assessments were blinded to QMRA flow status. Follow-up included monthly telephone calls for 12 months and biannual clinical visits (for a minimum of 12 months, and up to 24 months or the final visit). Enrollment took place from July 1, 2008, to July 31, 2013, with study completion on June 30, 2014; data analysis was performed from October 1, 2014, to April 10, 2015.

Exposure  Standard medical management of stroke risk factors.

Main Outcomes and Measures  The primary outcome was VB-territory stroke.

Results  Of the 82 enrolled patients, 72 remained eligible after central review of their angiograms. Sixty-nine of 72 patients completed the minimum 12-month follow-up; median follow-up was 23 (interquartile range, 14-25) months. Distal flow status was low in 18 of the 72 participants (25%) included in the analysis and was significantly associated with risk for a subsequent VB stroke (P = .04), with 12- and 24-month event-free survival rates of 78% and 70%, respectively, in the low-flow group vs 96% and 87%, respectively, in the normal-flow group. The hazard ratio, adjusted for age and stroke risk factors, in the low distal flow status group was 11.55 (95% CI, 1.88-71.00; P = .008). Medical risk factor management at 6-month intervals was similar between patients with low and normal distal flow. Distal flow status remained significantly associated with risk even when controlling for the degree of stenosis and location.

Conclusions and Relevance  Distal flow status determined using a noninvasive and practical imaging tool is robustly associated with risk for subsequent stroke in patients with symptomatic atherosclerotic VB occlusive disease. Identification of high-risk patients has important implications for future investigation of more aggressive interventional or medical therapies.

×